United States· US:0093-1025_11cdc932-271c-4988-aad9-076340888bce
Nefazodone Hydrochloride
A nefazodone product containing nefazodone hydrochloride, registered in United States by Teva Pharmaceuticals USA, Inc.. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nefazodone is registered in 4 of 19 countries.
Countries holding a registration under ATC N06AX06 (nefazodone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Nefazodone · ATC N06AX06
4 / 19 countries
- Finlandprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEFAZODONE HYDROCHLORIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Country
- United States (US)
- ATC code
- N06AX06
- ATC class
- Nefazodone
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11009310250660 TABLET in 1 BOTTLE (0093-1025-06)
- ndc110093-1025-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
410 interactions on record for nefazodone.
Graded by severity as the source publishes them — 144 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nefazodone · interactions on record
410 records
- 144 severe
- 215 moderate
- 8 minor
- 42 info
Most severe, free to view
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nefazodone in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1d74466-f4a9-49df-b6d3-74a73938c999 GET /v1/drugs/d1d74466-f4a9-49df-b6d3-74a73938c999?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "NEFAZODONE HYDROCHLORIDE",
"productndc": "0093-1025",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA076037",
"marketing_category": "ANDA"
}See everything about nefazodone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.